Event details

Put our diagnostics (Dx) team to work updating your DNA/RNA extraction or improving your current workflow with magnetic beads.


Stand a chance to receive products with a value of USD $5,000 from the genomics portfolio and a one-to-one virtual coaching session with a Cytiva Dx team member on optimizing their workflow*!


We are accepting ideas focusing on extraction of all forms of DNA or RNA from universities and companies (academic, start-ups, larger companies, and institutes) within EMEA and Asia pacific regions.


Select your research topic, register, and share your idea or project with us!


A panel of Cytiva judges will evaluate proposals based on relevance and potential for impact. Selected finalists will present to the panel, who will choose Dx Challenge winners from each region – EMEA and Asia Pacific.


Challenge winners will have the opportunity to collaborate alongside our experienced Dx team to bring their ideas to life. All finalists will have the ability to network with the team.


Submission period: 15 August – 30 December, 2022


*Terms and conditions apply. You may find more details in the section below.

Learn more

Thank you for your interest.


The registration period for the Dx Challenge is now closed.


Feel free to reach out to [email protected] if you have any enquiries regarding your submission for the Dx Challenge.


Panel 2 header

Lorem ipsum dolor sit amet, consectetur adipisicing elit. Repellendus aliquid tempore natus voluptates repudiandae, eos dolorem libero inventore, quod incidunt, asperiores. Reiciendis itaque enim pariatur, blanditiis minima autem quo a nulla, obcaecati quis, excepturi atque ab rerum! Sequi molestias vel eum, hic, perspiciatis eius suscipit reprehenderit molestiae vitae similique.

Learn more


About Cytiva Molecular Diagnostics Challenge

Learn more

We welcome innovative solutions with the potential to support disease identification and development of targeted therapies for precision health or improvements in sample preparation workflows.


This challenge is an open call for projects from universities and companies (academic, start-ups, larger companies, and institutes) within EMEA and Asia Pacific regions. Applicants must agree to provide Cytiva with the permission to publish research findings from the submitted proposal and have the ability to accept the products from genomics portfolio and interest to connect with a Cytiva Dx team member virtually on optimizing their workflow.

Have questions? Please contact us before applying.

Fill in your details in the registration form on this page.

  • The project must be innovative, developing a kit, assay or workflow which is not currently commercially available.
  • The project must not have been submitted or shared with Cytiva before or via other previous Cytiva challenges.
  • You must be willing to compare the performance of our Sera-Mag™ beads or Sera-Xtracta™ kits against your current solution and build into your submitted proposal.
  • Products used in the submitted research must be purchased from Cytiva or our approved distributors. Our Cytiva representatives will also reach out to you to support and ensure that you have the right materials for your research after registration.


Molecular Diagnostics Challenge Guidelines

Share these details about your idea or project:

  • What is the target molecule(s) to be extracted? What is your previous experience with this/these specific target molecule(s)?
  • Tell us about the sample type being analyzed.
  • What is the current method to extract the molecule and how does it compare with your new approach? (RNA, Plasmid DNA, etc.).
  • Why is it important to improve your approach?
  • How has the use of Sera-Mag™ beads or Sera-Xtracta™ kits helped to improve the overall workflow in terms of performance (binding capacity, speed, coverage, efficiency, etc.)?
  • What are your ideas for commercialization of the workflow / assay / kit: potential market size, end-users?
  • What steps were undertaken to reach your final conclusions?

Andrew Gane
G&Ds Solutions Strategy & Technology Manager


Andrew is the Product Strategy and Technology Manager within the Genomics and Diagnostic Solutions business responsible for building the innovation pipeline in collaboration with the R&D and commercial teams. His knowledge and understanding of emerging trends and new applications have been fundamental to developing the product portfolio into workflow-based solutions, with a particular focus on next-generation sequencing (NGS). Andrew has more than 30 years' experience in immunodiagnostics and molecular diagnostics in both lab-based and product development roles.




Chike Ejiofor
Product Manager, G&Ds – Magnetic Beads

Chike is a Product Manager for nucleic acid sample preparation in the Genomics and Diagnostic Solutions business in Cytiva, working with the R&D team to develop and optimize magnetic bead-based extraction solutions and supporting the commercial teams in their understanding of the NGS workflow, DNA sequencing, RNAi and Real-Time PCR. Chike has worked in the healthcare industry for over 15 years, after spending a year as a Research Scientist at the University of Westminster, where he focused on validating ATG-like genes in T. Vaginalis.

This challenge focuses on molecular diagnostics.

Examples of possible solutions and project scopes related to molecular diagnostics:
  • DNA and RNA extraction (Plasmid DNA, Genomic DNA etc.)
  • Improvement to traditional method (spin column, glass fiber etc.)

This Cytiva Immunoassay Rapid Test Challenge is open to EMEA and Asia Pacific corporations and research institutions.

Challenge entry runs from 15 August to 30 December, 2022.

Winners will be announced on 10 February, 2023.

The coaching session must take place before 29 March, 2023 either virtually or onsite, but arrangement of coaching session has to be confirmed with Cytiva before 24 February, 2023.

Prior to applying, please read the full terms and conditions of the Challenge which can be found via this link

1st – One (1) selected winner from EMEA and one (1) from Asia Pacific region will receive products to the value of $5,0001 from the genomics portfolio and a one-to-one virtual coaching session with a Cytiva Dx team member on optimizing their workflow.

2nd – Two (2) selected winners from EMEA and two (2) from Asia Pacific region will have a one-to-one virtual coaching session2 with a Cytiva Dx team member on optimizing their workflow.3

1The total prize value of USD $5,000 awarded to the final winner (Entrant) of Asia pacific and EMEA, will be calculated based on the actual value of Cytiva product as listed on Cytiva.com. Cytiva hold the rights to decide on the products to be awarded to winner based on the submitted workflow for the Cytiva Molecular Diagnostics Challenge.

2Virtual coaching session with a Cytiva Dx team member must take place before 29 March, 2023, but arrangement of coaching session has to be confirmed with Cytiva before 24 February 2023.

3If selected winner comprises more than 1 individual, winner can only send 1 representative to receive the 3-day coaching on assay development with a Cytiva Dx team member in our Cytiva lab at Dassel, Germany physically.


Follow our connected mAb perfusion process

There are many variations of passages of Lorem Ipsum available, but the majority have suffered alteration in some form, by injected humour, or randomised words which don't look even slightly believable. If you are going to use a passage of Lorem Ipsum, you need to be sure there isn't anything embarrassing hidden in the middle of text.

All the Lorem Ipsum generators on the Internet tend to repeat predefined chunks as necessary, making this the first true generator on the Internet. It uses a dictionary of over 200 Latin words, combined with a handful of model sentence structures, to generate Lorem Ipsum which looks reasonable. The generated Lorem Ipsum is therefore always free from repetition, injected humour, or non-characteristic words etc.

Latest video


About Cytiva
 

Did you know that Cytiva offers services that span from component customization to complete development of your molecular or immunodiagnostic assay from idea to commercialization? So, if you are looking to customize Whatman™ lateral flow pads and membranes or optimize the performance of magnetic beads, we can help you to accelerate the launch of your diagnostic assay. We work with complete transparency and empower you to solve challenges, too.

Cytiva panelist
Andrew Gane

Andrew is the Product Strategy and Technology Manager within the Genomics and Diagnostic Solutions business responsible for building the innovation pipeline in collaboration with the R&D and commercial teams. His knowledge and understanding of emerging trends and new applications have been fundamental to developing the product portfolio into workflow-based solutions, with a particular focus on next-generation sequencing (NGS). Andrew has more than 30 years' experience in immunodiagnostics and molecular diagnostics in both lab-based and product development roles.

Cytiva panelist
Chike Ejiofor

Chike is a Product Manager for nucleic acid sample preparation in the Genomics and Diagnostic Solutions business in Cytiva, working with the R&D team to develop and optimize magnetic bead-based extraction solutions and supporting the commercial teams in their understanding of the NGS workflow, DNA sequencing, RNAi and Real-Time PCR. Chike has worked in the healthcare industry for over 15 years, after spending a year as a Research Scientist at the University of Westminster, where he focused on validating ATG-like genes in T. Vaginalis.


Curious about continuous biomanufacturing? Join the Cytiva project team vlog series as we document our proof of concept trial and provide insights to help you efficiently plan and execute your project .

Publish date: 29 September, 2020

Curious about continuous biomanufacturing? Join the Cytiva project team vlog series as we document our proof of concept trial and provide insights to help you efficiently plan and execute your project .

Publish date: 29 September, 2020

Curious about continuous biomanufacturing? Join the Cytiva project team vlog series as we document our proof of concept trial and provide insights to help you efficiently plan and execute your project .

Publish date: 29 September, 2020

Curious about continuous biomanufacturing? Join the Cytiva project team vlog series as we document our proof of concept trial and provide insights to help you efficiently plan and execute your project .

Publish date: 29 September, 2020

Curious about continuous biomanufacturing? Join the Cytiva project team vlog series as we document our proof of concept trial and provide insights to help you efficiently plan and execute your project .

Publish date: 29 September, 2020

Curious about continuous biomanufacturing? Join the Cytiva project team vlog series as we document our proof of concept trial and provide insights to help you efficiently plan and execute your project .

Publish date: 29 September, 2020
About Cytiva
Did you know that Cytiva offers services that span from component customization to complete development of your molecular or immunodiagnostic assay from idea to commercialization?


So, if you are looking to customize Whatman™ lateral flow pads and membranes or optimize the performance of magnetic beads, we can help you to accelerate the launch of your diagnostic assay. We work with complete transparency and empower you to solve challenges, too.

Tab 2 Heading
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Duis commodo nisi ac elementum ultrices. Curabitur sollicitudin gravida ante vitae blandit. Vivamus eros eros, semper eget sapien vel, bibendum ultricies diam. Ut et diam neque. Ut velit enim, egestas at tortor ut, sagittis suscipit lacus. Morbi eleifend ultricies magna, at aliquam nisi. Sed faucibus nunc vel semper rutrum. Donec sit amet venenatis metus. Cras eget commodo ligula. Etiam vulputate arcu et velit iaculis, sed semper dui molestie. Morbi eget convallis ligula, a venenatis nisl. Cras imperdiet elementum venenatis. Quisque eu dolor hendrerit augue luctus tempus sed sit amet magna.
Tab 3 Heading
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Duis commodo nisi ac elementum ultrices. Curabitur sollicitudin gravida ante vitae blandit. Vivamus eros eros, semper eget sapien vel, bibendum ultricies diam. Ut et diam neque. Ut velit enim, egestas at tortor ut, sagittis suscipit lacus. Morbi eleifend ultricies magna, at aliquam nisi. Sed faucibus nunc vel semper rutrum. Donec sit amet venenatis metus. Cras eget commodo ligula. Etiam vulputate arcu et velit iaculis, sed semper dui molestie. Morbi eget convallis ligula, a venenatis nisl. Cras imperdiet elementum venenatis. Quisque eu dolor hendrerit augue luctus tempus sed sit amet magna.
Tab 4 Heading
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Duis commodo nisi ac elementum ultrices. Curabitur sollicitudin gravida ante vitae blandit. Vivamus eros eros, semper eget sapien vel, bibendum ultricies diam. Ut et diam neque. Ut velit enim, egestas at tortor ut, sagittis suscipit lacus. Morbi eleifend ultricies magna, at aliquam nisi. Sed faucibus nunc vel semper rutrum. Donec sit amet venenatis metus. Cras eget commodo ligula. Etiam vulputate arcu et velit iaculis, sed semper dui molestie. Morbi eget convallis ligula, a venenatis nisl. Cras imperdiet elementum venenatis. Quisque eu dolor hendrerit augue luctus tempus sed sit amet magna.

Form title

Form sub title